arginyl-glycyl-aspartic acid has been researched along with camptothecin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Aulicino, C; Bargiotti, A; Bucci, F; Castorina, M; Dal Pozzo, A; Dallavalle, S; Esposito, E; Foderà, R; Giannini, G; Musso, L; Ni, MH; Penco, S; Pisano, C; Vesci, L | 1 |
| Bucci, F; Castorina, M; Dal Pozzo, A; Esposito, E; Muzi, L; Ni, M; Penco, S; Pisano, C; Vesci, L | 1 |
| Chen, JX; Chen, WH; Li, C; Xiao, W; Zhang, XZ; Zhuo, RX | 1 |
| Bhuniya, S; Han, JH; Kang, C; Kim, JS; Kim, JY; Lee, MH; Sessler, JL | 1 |
| Deng, LH; Tang, CY; Tu, LX; Wu, CB; Xu, YH | 1 |
| Alloatti, D; Badaloni, E; Cabri, W; Castorina, M; Giannini, G; Pisano, C; Vesci, L | 1 |
| Jiang, Q; Liu, J; Luo, X; Yang, Z; Zhang, X | 1 |
| Bo, X; Chen, H; He, Y; Li, D; Li, P; Li, X; Xu, H; Zhang, K | 1 |
| Chen, M; Chen, X; Guo, Z; Tian, H; Xu, M; Zhou, X | 1 |
| Dong, K; Qu, X; Ren, J; Wang, Z; Zhang, L; Zhang, Y | 1 |
| Cao, P; Cheng, Y; Cui, J; Fan, S; Li, Y; Shang, Y; Yin, X; Zhang, H | 1 |
11 other study(ies) available for arginyl-glycyl-aspartic acid and camptothecin
| Article | Year |
|---|---|
Novel tumor-targeted RGD peptide-camptothecin conjugates: synthesis and biological evaluation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Female; Humans; Mice; Mice, Nude; Molecular Structure; Oligopeptides; Ovarian Neoplasms | 2010 |
Conjugates of a novel 7-substituted camptothecin with RGD-peptides as α(v)β₃ integrin ligands: An approach to tumor-targeted therapy.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Integrin alphaVbeta3; Ligands; Mice; Molecular Conformation; Oligopeptides; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured | 2010 |
A plug and play polymeric template driven by supramolecular interactions.
Topics: Animals; beta-Cyclodextrins; Camptothecin; Cell Death; Chlorocebus aethiops; COS Cells; Ethylenediamines; HeLa Cells; Humans; Magnetic Resonance Spectroscopy; Microscopy, Confocal; Naphthaleneacetic Acids; Oligopeptides; Peptides; Polymers; Spectrometry, Fluorescence | 2012 |
Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Cell Survival; Humans; Microscopy, Confocal; Naphthalimides; Neoplasms; Oligopeptides; Prodrugs | 2012 |
[In vivo imaging in tumor-bearing animals and pharmacokinetics of PEGylated liposomes modified with RGD cyclopeptide].
Topics: Animals; Area Under Curve; Camptothecin; Diagnostic Imaging; Drug Delivery Systems; Female; Fluorescent Dyes; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Polyethylene Glycols; Random Allocation; Rats; Rats, Sprague-Dawley; Spectroscopy, Near-Infrared; Tissue Distribution | 2012 |
Camptothecins in tumor homing via an RGD sequence mimetic.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Drug Delivery Systems; Female; Humans; Integrins; Male; Oligopeptides; Ovarian Neoplasms; Prostatic Neoplasms; Rats | 2012 |
Targeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Survival; Humans; Lipids; Materials Testing; MCF-7 Cells; Molecular Targeted Therapy; Nanocapsules; Oligopeptides; Polymers | 2013 |
Synergistic retention strategy of RGD active targeting and radiofrequency-enhanced permeability for intensified RF & chemotherapy synergistic tumor treatment.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cell Proliferation; Cell Survival; Combined Modality Therapy; Drug Delivery Systems; Drug Liberation; Fluorescent Dyes; HeLa Cells; Humans; Lactic Acid; Menthol; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pulsed Radiofrequency Treatment; Rats; Surface Properties | 2016 |
Dimeric camptothecin-loaded RGD-modified targeted cationic polypeptide-based micelles with high drug loading capacity and redox-responsive drug release capability.
Topics: Camptothecin; Cations; Drug Carriers; Drug Liberation; Humans; MCF-7 Cells; Micelles; Neoplasms; Oligopeptides; Oxidation-Reduction; Peptides; Polyethylene Glycols | 2017 |
Facile preparation of metal-organic frameworks-based hydrophobic anticancer drug delivery nanoplatform for targeted and enhanced cancer treatment.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Drug Carriers; HEK293 Cells; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Imidazoles; Metal-Organic Frameworks; Nanoparticles; Oligopeptides; Zeolites | 2019 |
Fluorescent Imaging-Guided Chemo- and Photodynamic Therapy of Hepatocellular Carcinoma with HCPT@NMOFs-RGD Nanocomposites.
Topics: Animals; Camptothecin; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Mice; Nanocomposites; Oligopeptides; Photochemotherapy; Zebrafish | 2022 |